Learn more →
Back to Expert Scholars
gi-oncology / gi-oncologyGastric Cancer

Yoon-Koo Kang

姜允久

MD, PhD

🏢Asan Medical Center, University of Ulsan College of Medicine(峨山医疗中心,蔚山大学医学院)🌐South Korea

Professor of Oncology; Chief, Department of Oncology肿瘤学教授;肿瘤科主任

88
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Prof. Yoon-Koo Kang at Asan Medical Center is a globally recognized leader in Asian gastric cancer research. He led ATTRACTION-2 establishing nivolumab in gastric cancer, conducted imatinib GIST trials, and has shaped Asian and global treatment guidelines for gastric cancer through prolific clinical investigation.

Share:

🧪Research Fields 研究领域

Gastric Cancer胃癌
PD-L1 ImmunotherapyPD-L1免疫治疗
Asian GI Oncology亚洲消化道肿瘤学
Antibody-Drug Conjugates抗体偶联药物

🎓Key Contributions 主要贡献

Nivolumab in Asian Gastric Cancer

Led ATTRACTION-2, the pivotal phase III trial demonstrating nivolumab improved OS versus placebo as third-line therapy in Asian patients with advanced gastric/GEJ cancer, enabling regulatory approval.

Imatinib for GIST

Contributed landmark Asian phase III data establishing imatinib as standard first-line treatment for advanced GIST, informing global guidelines and demonstrating consistent benefit across ethnic populations.

Representative Works 代表性著作

[1]

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

The Lancet (2017)

First phase III trial showing immunotherapy OS benefit in gastric cancer, establishing nivolumab as the first immune checkpoint inhibitor approved for this disease in Asia.

[2]

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD)

The Lancet (2014)

Pivotal trial demonstrating ramucirumab improved OS versus placebo in second-line gastric cancer, leading to the first anti-angiogenic monotherapy approval in this setting.

🏆Awards & Recognition 奖项与荣誉

🏆Korean Cancer Association Distinguished Achievement Award
🏆ASCO Merit Award
🏆Asia-Pacific Journal of Clinical Oncology Outstanding Contribution Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 姜允久 的研究动态

Follow Yoon-Koo Kang's research updates

留下邮箱,当我们发布与 Yoon-Koo Kang(Asan Medical Center, University of Ulsan College of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment